A 5392 New York Assembly · 2025 Regular Session

Expands the definition of epinephrine devices to include epinephrine nasal sprays

Summary
Defines epinephrine device as a single-use device or nasal spray device used for the automatic injection or administration of a premeasured dose of epinephrine into the human body for the purpose of emergency treatment of a person appearing to experience anaphylactic symptoms.
Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2025
Committee Review
Floor Vote
Governor
Introduced Feb 13, 2025 Last action Jun 12, 2025
Maddy AI version diff · 2 comparisons

What changed between versions

A5392A → A5392B · 3 edits
MINOR
This bill version adds the Insurance Law to the list of laws being amended and clarifies the legislative history by noting the bill was reprinted and recommitted to the committee twice. The substantive policy content regarding epinephrine devices remains unchanged from the previous version.
Scope change
The bill's scope was expanded to include the Insurance Law alongside the Public Health Law and Education Law, though the specific provisions in the text remain the same.
SCOPE

Added the Insurance Law to the list of laws being amended to expand the bill's legal scope.

TECHNICAL

Updated the bill number from A5392-A to A5392-B to reflect the amended version.

Added additional text to the legislative history section indicating the bill was reprinted and recommitted to the committee a second time.

Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
10
Key actions
4
Committee
2
Amendments
4
May 27, 2025
Committee
REPORTED REFERRED TO RULES
lower
May 21, 2025
Lower · Passed
PRINT NUMBER 5392B
lower
May 21, 2025
Lower · Passed
AMEND (T) AND RECOMMIT TO HEALTH
lower
May 9, 2025
Lower · Passed
PRINT NUMBER 5392A
lower
May 9, 2025
Lower · Passed
AMEND (T) AND RECOMMIT TO HEALTH
lower
Feb 13, 2025
Committee
REFERRED TO HEALTH
lower
1 primary · 3 co-sponsors

Sponsors